No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
30 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Gelb, Arthur F., M.D. · Individual
Who this trial is looking for
This trial is looking for current or former smokers with COPD, emphysema, and asthma-COPD overlap. Participants will help researchers understand why some people have trouble exhaling air.
Are You a Good Fit for This Trial?
You may be able to join if
I have asthma-COPD overlap
I have emphysema and a smoking history of more than 15 pack years
I have COPD or bronchitis and a smoking history of more than 15 pack years
You may not be able to join if
I am a non-smoker
I have another pulmonary diagnosis
I have pulmonary fibrosis
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarini…
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and PDE type 4 inhibitor. In some cases, the patient may have had a history of asthma preceding the development of COPD (Asthma COPD Overlap).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* asthma- copd overlap
* emphysema in smokers with smoking history \> 15 pack years
* COPD/ bronchitis and bronchiectasis in smokers with smoking history
* \>15 pack years
Exclusion Criteria:other pulmonary or systemic diagnosis
* non smokers
* any other pulmonary diagnosis
* …
Inclusion Criteria:
* asthma- copd overlap
* emphysema in smokers with smoking history \> 15 pack years
* COPD/ bronchitis and bronchiectasis in smokers with smoking history
* \>15 pack years
Exclusion Criteria:other pulmonary or systemic diagnosis
* non smokers
* any other pulmonary diagnosis
* pulmonary fibrosis
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.